{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T06:19:07Z","timestamp":1783837147742,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s43441-025-00868-x","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T13:17:05Z","timestamp":1756387025000},"page":"182-189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Descriptions of Abnormal Kidney Function in Contraindications: A Cross-Sectional Analysis of Japanese Prescription Drug Labeling Under the New Format"],"prefix":"10.1007","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4714-2183","authenticated-orcid":false,"given":"Masahiro","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momo","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3397-3939","authenticated-orcid":false,"given":"Mika","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9255-7541","authenticated-orcid":false,"given":"Tatsuya","family":"Okuwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4433-3864","authenticated-orcid":false,"given":"Katsuya","family":"Otori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"868_CR1","unstructured":"Ministry of Health. Labour and Welfare. Guideline for Descriptions in Package Inserts of Prescription Drugs. Notification No. Yakpra-An 0608-1; June 8, 2017 (in Japanese). https:\/\/www.mhlw.go.jp\/web\/t_doc?dataId=00tc2704%26dataType=1%26pageNo=1 (accessed August 6, 2025)."},{"key":"868_CR2","unstructured":"Ministry of Health. Labour and Welfare. Guideline for the Descriptions in Digitized Package Inserts of Prescription Drugs. Notification No. Yaku-An 0611-1; June 11, 2021 (in Japanese). https:\/\/www.mhlw.go.jp\/content\/11120000\/000805981.pdf (accessed August 6, 2025)."},{"key":"868_CR3","unstructured":"Ministry of Health. Labour and Welfare. Pharmaceutical Safety Division, Pharmaceutical and Food Safety Bureau. Notification on Promoting the Appropriate Use of Drugs in Patients with Renal Impairment. Administrative Communication; March 31, 2023 (in Japanese). https:\/\/www.mhlw.go.jp\/content\/11120000\/001060028.pdf (accessed August 6, 2025)."},{"key":"868_CR4","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/ki.2011.322","volume":"80","author":"GR Matzke","year":"2011","unstructured":"Matzke GR, Aronoff GR, Atkinson AJ Jr, et al. Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2011;80:1122\u201337.","journal-title":"Kidney Int"},{"key":"868_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH. Nephron. 1976;16:31\u201341.","journal-title":"Nephron"},{"key":"868_CR6","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"868_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3999\/jscpt.44.313","volume":"44","author":"A Kanda","year":"2013","unstructured":"Kanda A, Kawasaki A, Morita R, et al. Survey on renal function information in the package inserts of prescription drugs. Jpn J Clin Pharm Ther. 2013;44:313\u20138. (in Japanese).","journal-title":"Jpn J Clin Pharm Ther"},{"key":"868_CR8","first-page":"160","volume":"42","author":"Y Takeuchi","year":"2016","unstructured":"Takeuchi Y, Ohno Y, Izumi S, et al. Shortcomings in descriptions of drug package inserts regarding drug administration for patients with decreased renal function. Iryo-Yakugaku. 2016;42:160\u20137. (in Japanese).","journal-title":"Iryo-Yakugaku"},{"key":"868_CR9","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.3390\/jcm11071933","volume":"11","author":"L Weisbach","year":"2022","unstructured":"Weisbach L, Schuster AK, Hartmann M, et al. Inconsistencies and ambiguities in Liver-Disease-Related Contraindications-A systematic analysis of smpcs\/pi of major drug markets. J Clin Med. 2022;11:1933.","journal-title":"J Clin Med"},{"key":"868_CR10","doi-asserted-by":"publisher","first-page":"4167","DOI":"10.3390\/jcm11144167","volume":"11","author":"MI Then","year":"2022","unstructured":"Then MI, Andrikyan W, From MF, et al. Comprehensibility of contraindications in german, UK and US summaries of product characteristics\/prescribing Information-A comparative qualitative and quantitative analysis. J Clin Med. 2022;11:4167.","journal-title":"J Clin Med"},{"key":"868_CR11","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1592\/phco.30.8.776","volume":"30","author":"TC Dowling","year":"2010","unstructured":"Dowling TC, Matzke GR, Murphy JE, et al. Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches. Pharmacotherapy. 2010;30:776\u201386.","journal-title":"Pharmacotherapy"},{"key":"868_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12877-020-1485-4","volume":"20","author":"C Roux-Marson","year":"2020","unstructured":"Roux-Marson C, Baranski JB, Fafin C, et al. Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease. BMC Geriatr. 2020;20:87.","journal-title":"BMC Geriatr"},{"key":"868_CR13","unstructured":"U.S. Food and Drug Administration. Pharmacokinetics in patients with impaired renal function: study design, data analysis, and impact on dosing guidance for industry. Silver Spring (MD): FDA; 2024. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/pharmacokinetics-patients-impaired-renal-function-study-design-data-analysis-and-impact-dosing (accessed August 6, 2025)."},{"key":"868_CR14","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","volume":"105","author":"A Levin","year":"2024","unstructured":"Levin A, Ahmed SB, Carrero JJ, et al. Executive summary of the KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease: known knowns and known unknowns. Kidney Int. 2024;105:684\u2013701.","journal-title":"Kidney Int"},{"key":"868_CR15","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105:S117\u2013314.","journal-title":"Kidney Int"},{"key":"868_CR16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"Kidney Disease","year":"2012","unstructured":"Kidney Disease. Improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. 2012;2:S1\u2013138.","journal-title":"Kidney Int"},{"key":"868_CR17","unstructured":"Pharmaceuticals and Medical Devices Agency. PMDA Prescription Drug Information Search (in Japanese). https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuSearch\/ (accessed August 6, 2025)."},{"key":"868_CR18","unstructured":"Ministry of Health, Labour and Welfare. Pharmaceuticals and Medical Devices Safety Information No. 341. March, 2017. https:\/\/www.mhlw.go.jp\/file\/06-Seisakujouhou-11120000-Iyakushokuhinkyoku\/0000185474.pdf (accessed August 6, 2025)."},{"key":"868_CR19","doi-asserted-by":"crossref","unstructured":"Levey AS, Eckardt KU, Dorman NM et al. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 2020;97:1117\u20131129.","DOI":"10.1016\/j.diabres.2020.108248"},{"key":"868_CR20","unstructured":"World Health Organization. ATC\/DDD Toolkit. https:\/\/www.who.int\/tools\/atc-ddd-toolkit (accessed August 6, 2025)."},{"key":"868_CR21","unstructured":"Norwegian Institute of Public Health ATC\/DDD Index. https:\/\/atcddd.fhi.no\/atc_ddd_index\/ (accessed August 6, 2025)."},{"key":"868_CR22","unstructured":"JGraph Ltd. draw.io. https:\/\/www.drawio.com\/ (accessed August 6, 2025)."},{"key":"868_CR23","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/cpt.1167","volume":"105","author":"S Jeong","year":"2019","unstructured":"Jeong S, Kam G, Li J, et al. Assessment of consistency of drug interaction information in drug labels among the united states, the united kingdom, china, japan, and Korea. Clin Pharmacol Ther. 2019;105:505\u201314.","journal-title":"Clin Pharmacol Ther"},{"key":"868_CR24","volume-title":"Evidence-based CKD treatment guidelines 2023","author":"Japanese Society of Nephrology","year":"2023","unstructured":"Japanese Society of Nephrology. Evidence-based CKD treatment guidelines 2023. Tokyo: Igakusha; 2023. (in Japanese)."},{"key":"868_CR25","doi-asserted-by":"publisher","first-page":"sfaf073","DOI":"10.1093\/ckj\/sfaf073","volume":"18","author":"D Fern\u00e1ndez-Llaneza","year":"2025","unstructured":"Fern\u00e1ndez-Llaneza D, Hilbrands LB, Vogt L, et al. Identifying a cohort of hospitalized chronic kidney disease patients using electronic health records: lessons learnt and implications for future research and clinical practice guidelines. Clin Kidney J. 2025;18:sfaf073.","journal-title":"Clin Kidney J"},{"key":"868_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2215\/CJN.15691020","volume":"16","author":"SV Vestergaard","year":"2021","unstructured":"Vestergaard SV, Christiansen CF, Thomsen RW, et al. Identification of patients with CKD in medical databases: A comparison of different algorithms. Clin J Am Soc Nephrol. 2021;16:543\u201351.","journal-title":"Clin J Am Soc Nephrol"},{"key":"868_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s40264-024-01474-w","volume":"48","author":"D Fern\u00e1ndez-Llaneza","year":"2025","unstructured":"Fern\u00e1ndez-Llaneza D, Vos RMP, Lieverse JE, et al. An integrated approach for representing knowledge on the potential of drugs to cause acute kidney injury. Drug Saf. 2025;48:43\u201358.","journal-title":"Drug Saf"}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-025-00868-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-025-00868-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-025-00868-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:02:28Z","timestamp":1767150148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43441-025-00868-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["868"],"URL":"https:\/\/doi.org\/10.1007\/s43441-025-00868-x","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}